M11.18
Familial chondrocalcinosis, vertebrae
Clinical Classification Guidelines
Medical Intelligence & Overview
Familial chondrocalcinosis, also known as calcium pyrophosphate dihydrate (CPPD) disease, is a hereditary condition characterized by the deposit of calcium pyrophosphate crystals within the cartilage of joints and connective tissues. When this condition affects the vertebrae, it is classified under ICD-10 code M11.18. This form of chondrocalcinosis primarily influences the spine, leading to various structural and functional changes. Although often associated with aging, familial forms tend to have an earlier onset and a genetic component that predisposes affected individuals.
Causes & Symptoms
Clinical Causes: Inherited genetic mutations affecting the metabolism of cartilage and calcium deposition Family history of chondrocalcinosis or related joint diseases Possible associations with other metabolic disorders, such as hyperparathyroidism or hemochromatosis Environmental factors contributing to calcium crystal formation, though less prominent in hereditary cases
Key Symptoms: Chronic back pain, especially in the affected spinal regions Stiffness and limited range of motion in the spine Tenderness along the vertebral column Possible episodes of acute inflammation if crystals cause joint swelling Development of calcifications visible on imaging studies within the vertebral cartilage In some cases, nerve compression leading to neurological symptoms such as numbness or weakness
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a combination of clinical assessment, imaging studies, and laboratory tests. Key diagnostic measures include: - X-rays revealing calcifications within the intervertebral discs, facet joints, or cartilage of the spine. - MRI scans providing detailed images of soft tissues and identifying inflammation or nerve impingements. - Analysis of joint or tissue fluid, if aspirated, to detect calcium pyrophosphate crystals. - Blood tests to rule out other metabolic or inflammatory conditions. - Family medical history assessment to support a hereditary diagnosis.
Treatment Protocols: While there is no cure for familial chondrocalcinosis, treatment focuses on managing symptoms and preventing complications. Common approaches include: - Pain management using nonsteroidal anti-inflammatory drugs (NSAIDs) - Physical therapy to improve flexibility and strengthen supporting muscles - Corticosteroid injections to reduce inflammation during flare-ups - Lifestyle modifications to support spinal health, such as ergonomic adjustments and weight management - Regular monitoring with imaging to track progression and manage calcifications - In some cases, surgical intervention may be necessary to address nerve compression or structural deformities. It is important for individuals with this condition to work closely with healthcare providers to tailor a management plan suited to their specific needs.
Clinical Advice & FAQs
Billing Guidance
Is M11.18 a billable ICD-10 code?
Yes, M11.18 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M11.18?
Clinical documentation must specify the nature of Familial chondrocalcinosis, vertebrae and any associated comorbidities for accurate reporting.
Cite this Clinical Reference